DISTINGUISHED FACULTY OF DRUG DISCOVERY CHEMISTRY 2015

Plenary Keynotes 

Harren Jhoti, Ph.D., Astex Pharmaceuticals

Brian K. Shoichet, Ph.D., University of California, San Francisco

 

Alain Ajamian, Ph.D., Chemical Computing Group

Michelle Arkin, Ph.D., University of California, San Francisco

Yuko Ariza, Ph.D., Ono Pharmaceutical

Paramjit Arora, Ph.D., New York University

Phillip Black, Ph.D., Charles River

Doug C. Beshore, Ph.D., Merck Research Laboratories

Justin Bower, Ph.D., Beatson University

Nunzio Bottini, M.D., Ph.D., La Jolla Institute for Allergy and Immunology

Scott Breining, Ph.D., Asinex Corporation

Rogier C. Buijsman, Ph.D., Netherlands Translational Research Center B.V. (NTRC)

Amedeo Caflisch, Ph.D., University of Zurich

Jianhua Chao, Ph.D., Biogen Idec

Alessio Ciulli, Ph.D., University of Dundee

Seth M. Cohen, Ph.D., University of California, San Diego

Mary Ellen Digan, Ph.D., Novartis Institutes for BioMedical Research, Inc.

Kenneth Duncan, Ph.D., Epizyme

Donald Durden, M.D., Ph.D., UCSD School of Medicine and SignalRx Pharmaceuticals

Jörg Eder, Ph.D., Novartis Institutes for BioMedical Research

Daniel A. Erlanson, Ph.D., Carmot Therapeutics, Inc.

David P. Fairlie, Ph.D., University of Queensland

Rudi Fasan, Ph.D., University of Rochester

Benjamin Fauber, Ph.D., Genentech

Barry Finzel, Ph.D., University of Minnesota

Jiping Fu, Ph.D., Novartis

Andrei Gartel, Ph.D, University of Illinois, Chicago

Claire M. Gelfman, Ph.D., Ora, Inc.

Rocky Goldsmith, Ph.D., Chemical Computing Group

Mark Hixon, Ph.D., Takeda

Jan Hoflack, Ph.D., Oncodesign Biotechnology

Roderick E. Hubbard, Ph.D., Vernalis Research and University of York

Andrew L. Hopkins, DPhil, University of Dundee

Haitao (Mark) Ji, Ph.D., University of Utah

Ted W. Johnson, Ph.D., Pfizer Oncology

Robert M. Jones, Ph.D., Arena Pharmaceuticals

Jan Kihlberg, Ph.D., Uppsala University, Sweden

Roman Kombarov, Ph.D., Asinex Corporation

Alexandr P. Kornev, Ph.D., University of California, San Diego

Peter Kutchukian, Ph.D., Merck

Ravi G. Kurumbail, Ph.D., Pfizer

Tatiana Kutateladze, Ph.D., University of Colorado

David Langley, Ph.D., Bristol-Myers Squibb Co.

Gerald Lelais, Ph.D., The Genomics Institute of the Novartis Research Foundation (GNF)

Chenglong Li, Ph.D., The Ohio State University Comprehensive Cancer Center

Spiro Liras, Ph.D., Pfizer

Brian Lohse, Ph.D., University of Copenhagen

Jackie Macritchie, Ph.D., Charles River

Karen Maegley, Ph.D., Pfizer Oncology 

Steven Magnuson, Ph.D., Genentech

Roman Manetsch, Ph.D., Northeastern University

Elizabeth Martinez, Ph.D., University of Texas Southwestern Medical Center

Andreas Marzinzik, Ph.D., Novartis Institutes for BioMedical Research

Eric Marsault, Ph.D., University of Sherbrooke

Till Maurer, Ph.D., Structural Biology, Genentech

Shelli McAlpine, Ph.D., University of New South Wales

John A. McCauley, Ph.D., Merck 

Chris McBride, Takeda

Campbell McInnes, Ph.D., University of South Carolina

Mark McCoy, Ph.D., Merck

Troy Messick, Wistar Institute

Gerhard Mueller, Ph.D., MercaChem BV

Chudi Ndubaku, Ph.D., Genentech

Zaneta Nikolovska-Coleska, Ph.D., University of Michigan Medical School

Julen Oyarzabal, Ph.D., University of Navarra

Wylie Palmer, Ph.D., MD Anderson Cancer Center

Joe Patel, Ph.D., AstraZeneca

Snahel Patel, Genentech, Inc.

Zhonghua Pei, Ph.D., Genentech

Mark L. Peterson, Ph.D., Cyclenium Pharma, Inc.

Andrew Petros, Ph.D., AbbVie

Oliver Plettenburg, Ph.D., Sanofi-Aventis

Kamal Puri, Ph.D., Gilead Sciences, Inc.

Nir Qvit, Ph.D., Stanford University

Mark Sabat, Ph.D., Takeda

Eric Schwartz, Ph.D., Celgene Avilomics Research 

Mark Schnute, Ph.D., Pfizer Global R&D

Markus Seeliger, Ph.D., Stony Brook University

Michael H. Serrano-Wu, Ph.D., Broad Institute

Woody Sherman, Ph.D., Schrödinger

Gregg Siegal, Ph.D., ZoBio

Dan Sindhikara, Ph.D., Schrödinger

Yongcheng Song, Ph.D., Baylor College of Medicine

Alexander Statsyuk, Ph.D., Northwestern University

Terry Stouch, Ph.D., Science for Solutions, LLC

Ramzi Sweis, Ph.D., AbbVie, Inc.

Seng-Lai “Thomas” Tan, Ph.D., EMD Serono

Alex Taylor, Ph.D., Constellation Pharmaceuticals 

Nicholas Terrett, Ph.D., Ensemble

Bill Thomas, Ph.D., Pharmacyclics

Aaron Thompson, Ph.D., Dart Neuroscience

Maricel Torrent, Ph.D., AbbVie

Douglas A. Treco, Ph.D., Ra Pharmaceuticals, Inc.

Sandor Vajda, Ph.D., Boston University

Huanchen Wang, Ph.D., NIH

Scot R. Weinberger, Molecular Sensing, Inc.

Adrian Whitty, Ph.D., Boston University

Anthony William, Ph.D., A*STAR-ICES

Alison Woolford, Ph.D., Astex Pharmaceuticals

Hang Hubert Yin, Ph.D., University of Colorado

Christoph Zapf, Ph.D., Pfizer Research Labs

Edward R. Zartler, Ph.D., Quantum Tessera Consulting

Zhihao Zhuang, Ph.D., University of Delaware